Amneal Pharmaceuticals, Inc.
AMRXNasdaqCIK 1723128HealthcareFiscal year ends Dec 31
Reports and events: 189 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001140361-26-040656 |
| 2026-08-1218:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000898432-26-000654 |
| 2026-08-1218:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000898432-26-000653 |
| 2026-08-1218:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000898432-26-000652 |
| 2026-08-1016:05 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-032014 |
| 2026-08-0617:19 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001723128-26-000031 |
| 2026-08-0316:28 ET | 8-K | 1.01 Entry into a material agreement | 0001628280-26-051900 |
| 2026-07-3116:08 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-030491 |
| 2026-07-3006:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-26-000025 |
| 2026-05-0716:22 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001723128-26-000020 |
| 2026-05-0716:15 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-032137 |
| 2026-05-0716:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001723128-26-000019 |
| 2026-04-2206:22 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-168231 |
| 2026-03-2618:23 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000898432-26-000204 |
| 2026-03-2516:15 ET | DEF 14A | Proxy statementPeriod 2026-05-06 | 0001308179-26-000143 |
| 2026-02-2716:19 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001723128-26-000011 |
| 2026-02-2706:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-26-000008 |
| 2026-02-0318:36 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001628280-26-004738 |
| 2026-01-2816:16 ET | 8-K | 8.01 Other events | 0001628280-26-003842 |
| 2026-01-1307:44 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001723128-26-000003 |
| 2025-11-0616:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001723128-25-000062 |
| 2025-10-3006:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-25-000059 |
| 2025-10-0719:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000898432-25-000809 |
| 2025-10-0615:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000898432-25-000785 |
| 2025-08-0821:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000898432-25-000584 |
| 2025-08-0716:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001723128-25-000047 |
| 2025-08-0516:39 ET | 8-K/A | 5.07 Shareholder vote results | 0001723128-25-000040 |
| 2025-08-0506:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-25-000037 |
| 2025-08-0116:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950103-25-009701 |
| 2025-07-2417:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-009253 |
| 2025-07-2107:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-009025 |
| 2025-07-2107:41 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-25-000033 |
| 2025-05-0816:21 ET | 8-K | 5.07 Shareholder vote results | 0001723128-25-000024 |
| 2025-05-0716:39 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001723128-25-000022 |
| 2025-05-0206:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-25-000018 |
| 2025-03-2516:15 ET | DEF 14A | Proxy statementPeriod 2025-05-06 | 0001308179-25-000220 |
| 2025-03-1716:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000898432-25-000189 |
| 2025-03-0616:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001723128-25-000014 |
| 2025-02-2816:53 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001723128-25-000012 |
| 2025-02-2806:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-25-000009 |
| 2025-01-2317:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000898432-25-000062 |
| 2025-01-1506:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001723128-25-000005 |
| 2024-11-1216:25 ET | 8-K/A | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-24-000044 |
| 2024-11-1216:17 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001723128-24-000042 |
| 2024-11-0806:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-24-000037 |
| 2024-10-3118:51 ET | SC 13D/A | Ownership report, active investor, amended | 0000898432-24-000861 |
| 2024-10-0107:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-041646 |
| 2024-08-0916:27 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001723128-24-000032 |
| 2024-08-0906:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-24-000030 |
| 2024-05-1316:15 ET | SC 13D/A | Ownership report, active investor, amended | 0000898432-24-000401 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.